274 related articles for article (PubMed ID: 26773005)
1. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization.
Takano S; Reichert M; Bakir B; Das KK; Nishida T; Miyazaki M; Heeg S; Collins MA; Marchand B; Hicks PD; Maitra A; Rustgi AK
Genes Dev; 2016 Jan; 30(2):233-47. PubMed ID: 26773005
[TBL] [Abstract][Full Text] [Related]
2. PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
Marchand B; Pitarresi JR; Reichert M; Suzuki K; Laczkó D; Rustgi AK
Oncogene; 2019 May; 38(22):4325-4339. PubMed ID: 30705403
[TBL] [Abstract][Full Text] [Related]
3. The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis.
Reichert M; Takano S; von Burstin J; Kim SB; Lee JS; Ihida-Stansbury K; Hahn C; Heeg S; Schneider G; Rhim AD; Stanger BZ; Rustgi AK
Genes Dev; 2013 Feb; 27(3):288-300. PubMed ID: 23355395
[TBL] [Abstract][Full Text] [Related]
4. PRRX1 isoform PRRX1A regulates the stemness phenotype and epithelial-mesenchymal transition (EMT) of cancer stem-like cells (CSCs) derived from non-small cell lung cancer (NSCLC).
Sun L; Han T; Zhang X; Liu X; Li P; Shao M; Dong S; Li W
Transl Lung Cancer Res; 2020 Jun; 9(3):731-744. PubMed ID: 32676335
[TBL] [Abstract][Full Text] [Related]
5. Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.
Weng CC; Hsieh MJ; Wu CC; Lin YC; Shan YS; Hung WC; Chen LT; Cheng KH
Mol Cancer; 2019 May; 18(1):96. PubMed ID: 31109321
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology.
Feldmann K; Maurer C; Peschke K; Teller S; Schuck K; Steiger K; Engleitner T; Öllinger R; Nomura A; Wirges N; Papargyriou A; Jahan Sarker RS; Ranjan RA; Dantes Z; Weichert W; Rustgi AK; Schmid RM; Rad R; Schneider G; Saur D; Reichert M
Gastroenterology; 2021 Jan; 160(1):346-361.e24. PubMed ID: 33007300
[TBL] [Abstract][Full Text] [Related]
7. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
8. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.
Wang L; Yang H; Abel EV; Ney GM; Palmbos PL; Bednar F; Zhang Y; Leflein J; Waghray M; Owens S; Wilkinson JE; Prasad J; Ljungman M; Rhim AD; Pasca di Magliano M; Simeone DM
Genes Dev; 2015 Jan; 29(2):171-83. PubMed ID: 25593307
[TBL] [Abstract][Full Text] [Related]
9. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
10. PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance.
Roy N; Takeuchi KK; Ruggeri JM; Bailey P; Chang D; Li J; Leonhardt L; Puri S; Hoffman MT; Gao S; Halbrook CJ; Song Y; Ljungman M; Malik S; Wright CV; Dawson DW; Biankin AV; Hebrok M; Crawford HC
Genes Dev; 2016 Dec; 30(24):2669-2683. PubMed ID: 28087712
[TBL] [Abstract][Full Text] [Related]
11. CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma.
Teodorczyk M; Kleber S; Wollny D; Sefrin JP; Aykut B; Mateos A; Herhaus P; Sancho-Martinez I; Hill O; Gieffers C; Sykora J; Weichert W; Eisen C; Trumpp A; Sprick MR; Bergmann F; Welsch T; Martin-Villalba A
Cell Death Differ; 2015 Jul; 22(7):1192-202. PubMed ID: 25613377
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
13. Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer.
Koizumi M; Hiasa Y; Kumagi T; Yamanishi H; Azemoto N; Kobata T; Matsuura B; Abe M; Onji M
PLoS One; 2013; 8(8):e71367. PubMed ID: 23940742
[TBL] [Abstract][Full Text] [Related]
14. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
[TBL] [Abstract][Full Text] [Related]
15. The TALE homeodomain transcription factor MEIS1 activates the pro-metastatic melanoma cell adhesion molecule Mcam to promote migration of pancreatic cancer cells.
von Burstin J; Bachhuber F; Paul M; Schmid RM; Rustgi AK
Mol Carcinog; 2017 Mar; 56(3):936-944. PubMed ID: 27583552
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells.
Dalla Pozza E; Dando I; Biondani G; Brandi J; Costanzo C; Zoratti E; Fassan M; Boschi F; Melisi D; Cecconi D; Scupoli MT; Scarpa A; Palmieri M
Int J Oncol; 2015 Mar; 46(3):1099-108. PubMed ID: 25502497
[TBL] [Abstract][Full Text] [Related]
17. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
18. LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.
Zhao T; Ren H; Li J; Chen J; Zhang H; Xin W; Sun Y; Sun L; Yang Y; Sun J; Wang X; Gao S; Huang C; Zhang H; Yang S; Hao J
Cancer Res; 2015 Jan; 75(1):111-9. PubMed ID: 25385028
[TBL] [Abstract][Full Text] [Related]
19. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
20. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma.
Kohler I; Bronsert P; Timme S; Werner M; Brabletz T; Hopt UT; Schilling O; Bausch D; Keck T; Wellner UF
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():78-84. PubMed ID: 25827809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
